Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous bone marrow cell transplantation in acute spinal cord injury
NCT02260713Phase 2Completed
- Sponsor
- Indian Spinal Injuries Centre
- Start
- Feb 2011
- Primary completion
- Nov 2017
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in acute spinal cord injury (SCI), sponsored by Indian Spinal Injuries Centre. Primary endpoint: American Spinal Injury Association classification at 5 years. Started Feb 2011; status: completed.
02
Conditions
acute spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT02260713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02260713.